会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 35. 发明授权
    • Processes for the production of 3'-deoxykanamycin A and intermediates
    • 制备3'-脱氧卡那霉素A和中间体的方法
    • US4357466A
    • 1982-11-02
    • US198612
    • 1980-10-20
    • Hamao UmezawaSumio UmezawaTsutomu TsuchiyaTomo Jikihara
    • Hamao UmezawaSumio UmezawaTsutomu TsuchiyaTomo Jikihara
    • C07H15/234C07H15/236A61K31/71C07H15/22
    • C07H15/234
    • 3'-Deoxykanamycin A useful as antibacterial agent is produced from a protected kanamycin A derivative either by a process comprising imidazolylthiocarbonylation of the 3'- and 2"-hydroxyl groups of 4",6"-O-cyclohexylidene-4'-0:6'-N-carbonyl-5,2'-O-isopropylidene-1,3,3"-tri-N-tosylkanamycin A, preferential removal of the 3'-imidazolylthiocarbonyloxy group with tributyltin hydride for the 3'-deoxygenation, followed by removal of the 2"-O-imidazolylthiocarbonyl group with aqueous ammonia, removal of the N-tosyl groups with alkali or alkaline earth metal in liquid ammonia, hydrolytic fission of the 4',6'-cyclic carbamate ring and concurrent removal of the 5,2'-O-isopropylidene group and 4",6"-O-cyclohexylidene group, or by a process comprising selective acetylation of the 2"-hydroxyl group of said protected kanamycin A derivative with acetyl chloride in pyridine, trifluoromethanesulfonylation of the 3'-hydroxyl group, followed by concurrent removal of the 3'-trifluoromethanesulfonyloxy group and N-tosyl groups with alkali metal in liquid ammonia, removal of the 2"-O-acetyl group concurrently with hydrolytic fission of 4',6'-cyclic carbamate, and hydrolytic removal of the 5,2'-O-isopropylidene and 4",6"-O-cyclohexylidene groups.
    • 可用作抗菌剂的3'-脱氧卡那霉素A由受保护的卡那霉素A衍生物制备,其通过包含4',6“-O-亚环己基-4'的3'和2” - 羟基的咪唑基硫代羰基化的方法制备, -0:6'-N-羰基-5,2'-O-异亚丙基-1,3,3“ - 三-N-甲苯磺酰基卡那霉素A,优选用三丁基氢化锡将3'-咪唑硫基羰基氧基除去3' 脱氧,然后用氨水除去2“-O-咪唑基硫代羰基,在液氨中用碱金属或碱土金属除去N-甲苯磺酰基,4',6'-环状氨基甲酸酯环的水解裂变 并且同时去除5,2'-O-异亚丙基和4“,6”-O-亚环己基,或通过包括将所述受保护的卡那霉素A衍生物的2'-羟基选择性乙酰化的方法与 吡啶中的乙酰氯,3'-羟基的三氟甲磺酰化,然后同时除去3'-三氟甲磺酸 氧基和N-甲苯磺酰基与液氨中的碱金属反应,与4',6'-环状氨基甲酸酯的水解裂解同时除去2'-乙酰基,并除去5,2'-O 异亚丙基和4“,6”-O-亚环己基。
    • 37. 发明授权
    • Tylosin derivatives
    • 泰乐菌素衍生物
    • US4438109A
    • 1984-03-20
    • US285747
    • 1981-07-22
    • Hamao UmezawaSumio UmezawaTsutomu TsuchiyaAkihiro Tanaka
    • Hamao UmezawaSumio UmezawaTsutomu TsuchiyaAkihiro Tanaka
    • C07H17/08A61K31/70
    • C07H17/08
    • Tylosin derivatives shown by the general formula ##STR1## wherein R represents a hydrogen atom or a hydroxyl group; R.sub.1 represents a halogen atom, a hydroxyl group, a tetrahydrofuranyloxy group, a tetrahydropyranyloxy group, a tetrahydrothiofuranyloxy group, a tetrahydrothiopyranyloxy group, an alkanoyloxy group, an arylcarbonyloxy group, an aralkylcarbonyloxy group, a lower alkylthiomethyloxy group, a heterocyclic thio group which may have a substituent, a mono- or di- lower alkylamino lower alkylthio group or a group of ##STR2## (wherein R.sub.4 represents a hydroxyl group or an alkanoyloxy group); R.sub.2 represents a hydrogen atom, a hydroxyl group, or an alkanoyloxy group; R.sub.3 represents a hydroxyl group or an alkanoyloxy group; and represents a single bond or a double bond, but represents a double bond when R.sub.2 is a hydrogen atom.These compounds are useful as antibiotics.
    • 由通式表示的泰乐菌素衍生物,其中R表示氢原子或羟基; R 1表示卤素原子,羟基,四氢呋喃氧基,四氢吡喃氧基,四氢噻喃氧基,四氢噻喃氧基,烷酰氧基,芳基羰基氧基,芳烷基羰基氧基,低级烷基硫代甲氧基,可具有的杂环硫基 取代基,单 - 或二 - 低级烷基氨基低级烷硫基或一组(其中R 4表示羟基或烷酰氧基)。 R2表示氢原子,羟基或烷酰氧基; R3表示羟基或烷酰氧基; 并且表示单键或双键,但当R 2为氢原子时,表示双键。 这些化合物可用作抗生素。
    • 38. 发明授权
    • 3',4'-Dideoxykanamycin A and
1-N-(S)-.alpha.-hydroxy-.omega.-aminoalkanoyl) derivatives thereof
    • 3',4'-双脱氧卡那霉素A和1-N-(S)-α-羟基-ω-氨基烷酰基)衍生物
    • US4298727A
    • 1981-11-03
    • US114779
    • 1980-01-23
    • Hamao UmezawaSumio UmezawaTsutomu TsuchiyaTomo JikaharaToshiaki Miyake
    • Hamao UmezawaSumio UmezawaTsutomu TsuchiyaTomo JikaharaToshiaki Miyake
    • C07H15/234A61K31/70A61K31/7028A61K31/7034A61K31/7036A61P31/04C07H15/236C07H15/22
    • C07H15/234Y02P20/55
    • 3',4'-Dideoxy derivative and 1-N-((S)-.alpha.-hydroxy-.omega.-aminoalkanoyl)-3',4'-dideoxy derivative of kanamycin A are now synthetized from kanamycin A and show a wider and/or higher antibacterial activity than the parent kanamycin A so that they are useful in therapeutic treatment of infections by gram-negative and gram-positive bacteria, including drug-resistant strains thereof. The production of these new derivatives may be made by preparing a protected kanamycin A derivative having its 3'- and 4'-hydroxyl groups unprotected and having its all or substantially all other functional groups protected from the initial material, kanamycin A, sulfonylating the 3'- and 4'-hydroxyl groups, removing the 3'- and 4'-sulfonyloxy groups from the resulting 3',4'-di-sulfonic acid ester product to give a 3'-eno-kanamycin A derivative, hydrogenating the 3'-eno-kanamycin A derivative to saturate the 3',4'-unsaturated bond and to yield a protected 3',4'-dideoxykanamycin A product, followed by removal of the remainiing protective groups, and optionally further followed by 1-N-acylation of the 1-amino group of the resulting 3',4'-dideoxykanamycin A with an (S)-.alpha.-hydroxy-.omega.-aminoalkanoic acid or its reactive equivalent.
    • 卡那霉素A的3',4'-二脱氧衍生物和1-N - ((S)-α-羟基-ω-氨基烷酰基)-3',4'-二脱氧衍生物现在从卡那霉素A合成并显示出更宽和/ 或更高的抗菌活性,使得它们可用于革兰氏阴性和革兰氏阳性细菌(包括其耐药菌株)的感染的治疗性治疗。 这些新衍生物的生产可以通过制备其未被保护的3'和4'-羟基的保护的卡那霉素A衍生物和其全部或基本上所有其它保护起始材料的卡那霉素A的其他官能团来制备,磺酰化3 '和4'-羟基,从所得的3',4'-二磺酸酯产物中除去3'-和4'-磺酰氧基,得到3'-烯 - 卡那霉素A衍生物,将3 ' - 卡那霉素A衍生物使3',4'-不饱和键饱和并产生受保护的3',4'-二脱氧卡那霉素A产物,然后除去剩余的保护基,并且任选地进一步加入1-N 所得的3',4'-二脱氧卡那霉素A的1-氨基酸与(S)-α-羟基-ω-氨基链烷酸或其反应性等同物的酰基化。